DASH vs MTNB · P/E 76, rev $13.72B vs rev $1.1M
DoorDash, Inc. Class A Common Stock (DASH) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the DASH and MTNB stock pages for the full models.
Not investment advice.